Case Details
- Citation: [2013] SGHC 2
- Court: High Court of the Republic of Singapore
- Date: 10 January 2013
- Judge: Choo Han Teck J
- Case Title: Biomedia Pharma Pte Ltd (formerly known as Malaysia Chemist Pte Ltd) v TAC Distribution Pte Ltd (trading as Trane Singapore) (Amcrotech Pte Ltd, third party)
- Case Number: Suit No 143 of 2009 (assessment of damages)
- Tribunal/Court Stage: Assessment of damages following liability judgment
- Coram: Choo Han Teck J
- Plaintiff/Applicant: Biomedia Pharma Pte Ltd (formerly known as Malaysia Chemist Pte Ltd)
- Defendant/Respondent: TAC Distribution Pte Ltd (trading as Trane Singapore)
- Third Party: Amcrotech Pte Ltd
- Legal Area: Contract – Remedies – Damages
- Decision Type: Quantum of damages assessed; counterclaim and third party action dismissed earlier
- Counsel for Plaintiff: Mansurhusain Akbar Hussein (Jacob Mansur & Pillai)
- Counsel for Defendant: Niru Pillai (Global Law Alliance LLC)
- Counsel for Third Party: Michael Chia Peng Chuang (Pereira & Tan LLC)
- Prior Liability Judgment: Judgment in favour of plaintiff for breach of contract dated 8 November 2010
- Damages Assessment Hearing: July 2012
- Verdict on Quantum (earlier in assessment): 24 September 2012
- Judgment Length: 2 pages, 565 words
- Cases Cited: [2013] SGHC 2 (as provided in metadata)
- Statutes Referenced: (not specified in provided extract)
Summary
This High Court decision concerns the assessment of damages after the court had already found that TAC Distribution Pte Ltd (“TAC”) breached a contract to design and install a specialised air-conditioning system for Biomedia Pharma Pte Ltd (“Biomedia”). The earlier liability judgment, delivered on 8 November 2010, held TAC liable for breach of contract and dismissed TAC’s counterclaim and its third-party action. The present judgment, delivered on 10 January 2013 by Choo Han Teck J, focuses on quantum: what damages Biomedia should receive to compensate for the consequences of TAC’s failure to deliver a system that complied with the contractual requirements.
The court awarded Biomedia a total of $185,000. This comprised $135,000 as reimbursement of the sum paid by Biomedia to TAC, and an additional $50,000 in general damages. The court accepted that the $135,000 was recoverable because TAC failed to hand over a compliant system, which in turn led to regulatory consequences: the Health Sciences Authority (“HSA”) withheld Biomedia’s licence to use the factory as a dry laboratory. While TAC argued that Biomedia should not recover both a refund and general damages, the court reasoned that the refund addressed a proved element of loss (payment made for non-compliant performance), whereas the general damages addressed an additional, non-precisely measurable element of harm (inconvenience, trouble, and business disruption) that was not fully captured by the reimbursement.
What Were the Facts of This Case?
Biomedia leased a factory building to operate its pharmaceutical business. The business required the factory to be used as a “dry laboratory”, a regulatory and operational classification that depended on compliance with requirements administered by the Health Sciences Authority. Biomedia therefore needed a specialised environmental control system to meet the conditions necessary for the intended laboratory use.
TAC was engaged as a specialist in air-conditioning systems. Under the contract, TAC undertook to design and install a specialised air-conditioning system for Biomedia’s factory. Although TAC was the contracting party, the actual installation work was carried out by a third party, Amcrotech Pte Ltd. The contractual structure thus involved TAC’s responsibility for design and installation outcomes, with Amcrotech performing the physical installation.
After installation, it became clear that the system did not comply with the contractual requirements. The court had already found in the liability judgment that TAC failed to hand over a system that complied with the contract. This failure had consequences beyond mere technical non-conformity. In particular, the HSA withheld the grant of Biomedia’s licence to use the factory as a dry laboratory. This regulatory withholding directly affected Biomedia’s ability to operate its pharmaceutical business from the leased premises.
Following the liability finding, damages were assessed. The assessment proceeded in July 2012, and the court delivered its verdict on quantum on 24 September 2012. The present judgment records the court’s reasoning on the damages assessment, including how the court treated the relationship between reimbursement of the contract payment and the award of general damages for the broader consequences of the breach.
What Were the Key Legal Issues?
The central legal issue was how to quantify damages for breach of contract where the defendant’s non-compliant performance led to regulatory consequences and business disruption. In particular, the court had to determine whether Biomedia’s damages should include (i) reimbursement of the amount paid under the contract and (ii) additional general damages for the inconvenience and trouble caused by the breach.
A second, more focused issue arose from TAC’s argument that Biomedia should not recover both a refund (reimbursement of the $135,000 paid) and general damages. TAC’s position, as presented through counsel, was that awarding both would amount to double recovery or would otherwise be inconsistent with the proper measure of damages for the breach. The court therefore had to consider the conceptual overlap between restitutionary-like reimbursement and compensatory general damages.
Finally, the court had to address causation and attribution. The court did not assume that all of Biomedia’s business closure (or business harm) was wholly attributable to TAC’s breach. Instead, it had to decide how to value the portion of harm that was a probable contribution to the closure, and how to approach damages where the loss is partly measurable (the payment made) and partly non-quantifiable (inconvenience, trouble, and business disruption).
How Did the Court Analyse the Issues?
Choo Han Teck J began by situating the damages assessment within the procedural history. The court had already found liability for breach of contract and ordered damages to be assessed. The defendant’s counterclaim and third-party action had been dismissed. The assessment therefore proceeded on the basis that TAC’s breach was established and that the remaining task was to determine the appropriate quantum.
On the measurable component of loss, the court accepted that the $135,000 should be awarded as reimbursement of the sum paid by Biomedia to TAC. Importantly, the payment itself was not disputed. TAC’s defence was framed as a denial of “failure of consideration”. However, the court found that the system delivered did not comply with the contract. Where the defendant fails to provide the contractual performance, the consideration for the payment fails in substance: Biomedia paid for a compliant system and did not receive what it contracted for. The court therefore treated the reimbursement as a proved element of loss arising from the breach.
The court then addressed the regulatory and operational consequences of the breach. It was “clear” that TAC’s breach resulted in the HSA withholding Biomedia’s licence to use the factory as a dry laboratory. This fact supported the conclusion that the breach had real-world consequences for Biomedia’s ability to operate. The court’s reasoning indicates that damages were not limited to technical defects; they extended to the downstream effects that were sufficiently connected to the breach.
Turning to the argument against double recovery, the court engaged with counsel’s submission that Biomedia should not be awarded the refund and still recover general damages. The court agreed with the defendant only to a limited extent: it accepted that other claims made by Biomedia were special damages that had not been pleaded, and therefore could not be awarded. This reflects a procedural discipline in damages pleading—special damages must be specifically pleaded to be recoverable. However, the court distinguished the reimbursement of $135,000 from the general damages component. The reimbursement addressed a clearly proved element of loss: the payment made for non-compliant performance. General damages addressed a different category of harm: inconvenience and trouble that could not be precisely assessed.
In valuing the general damages, the court adopted a pragmatic approach. It recognised that the loss in business could not be assumed to be wholly attributable to TAC’s breach. The breach was a “probable contribution” to the closure of Biomedia’s business, but causation was not absolute. The court therefore had to determine how to value a loss that is partly attributable and partly non-quantifiable. It identified relevant factors to guide the assessment: the nature of the business, the consequence of the breach, the nature and size of the contract, and the nature of the breach. These factors reflect the court’s attempt to calibrate general damages to the context and seriousness of the breach rather than to apply a rigid formula.
Applying these considerations, the court added $50,000 to the reimbursement amount, making the total award $185,000. The reasoning shows that the court treated general damages as compensating for the intangible and operational disruption caused by the breach—disruption that was not fully captured by refunding the contract payment. In other words, the court’s approach was to avoid both under-compensation (by awarding only reimbursement) and over-compensation (by awarding special damages that were not pleaded or by assuming all business loss was caused by the breach).
What Was the Outcome?
The court awarded Biomedia damages totalling $185,000. The award consisted of $135,000 as reimbursement of the sum paid by Biomedia to TAC, and $50,000 in general damages for the inconvenience and trouble suffered due to TAC’s breach. The court’s decision thus confirmed that reimbursement of the contract payment and general damages could both be awarded where they compensate different elements of loss and where the general damages are supported by evidence of harm that is not amenable to precise quantification.
In addition, the court’s earlier procedural rulings remained in effect: TAC’s counterclaim and its third-party action had been dismissed. The practical effect of the decision is that TAC bore liability for the financial and operational consequences of delivering a non-compliant air-conditioning system that prevented Biomedia from obtaining the necessary HSA licence to use the premises as a dry laboratory.
Why Does This Case Matter?
This case is useful for practitioners because it illustrates a structured approach to damages assessment in contract disputes involving non-compliant performance and regulatory consequences. The court’s reasoning demonstrates that where the defendant’s breach leads to a failure to obtain regulatory approval necessary for the claimant’s intended use of premises, damages may extend beyond the cost of repair or technical defect. The court treated the regulatory withholding of the licence as a clear consequence of the breach, supporting the award of both reimbursement and general damages.
From a doctrinal perspective, the decision is also instructive on the relationship between reimbursement (refund) and general damages. While the defendant argued against recovering both, the court’s analysis clarifies that the prohibition against double recovery is not absolute; rather, it depends on whether the heads of loss overlap. Here, reimbursement addressed the proved payment for non-compliant performance, whereas general damages addressed additional harm—such as inconvenience, trouble, and business disruption—that was not precisely measurable. This distinction can guide lawyers when structuring pleadings and submissions on damages.
Finally, the judgment highlights the importance of pleading discipline for special damages. The court refused to award other claims because they were special damages that had not been pleaded. This serves as a practical reminder that even where liability is established, the scope of recoverable damages may be constrained by procedural requirements. For law students and litigators, the case provides a clear example of how courts may separate pleaded and unpleaded heads of loss, and how general damages may still be awarded for non-quantifiable consequences even when special damages are not properly pleaded.
Legislation Referenced
- (Not specified in the provided judgment extract.)
Cases Cited
- [2013] SGHC 2
Source Documents
This article analyses [2013] SGHC 2 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.